Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction.
Seung-Jae JooSong Yi KimJoon-Hyouk ChoiHyeung Keun ParkJong Wook BeomJae-Geun LeeShung Chull ChaeHyo-Soo KimYoung Jo KimMyeong-Chan ChoChong Jin KimSeung-Woon RhaJunghan YoonMyung Ho JeongPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Beta-blocker therapy at discharge was associated with better 1-year clinical outcomes in patients with reduced or mid-range LVEF after AMI, but not in patients with preserved LVEF. These data suggested that the long-term beta-blocker therapy may be guided by LVEF.
Keyphrases
- acute myocardial infarction
- left ventricular
- heart failure
- angiotensin converting enzyme
- percutaneous coronary intervention
- hypertrophic cardiomyopathy
- blood pressure
- oxidative stress
- stem cells
- mitral valve
- electronic health record
- aortic stenosis
- left atrial
- big data
- bone marrow
- angiotensin ii
- aortic valve
- atrial fibrillation